Tuberculosis Testing

TB Risk Groups

Who is at risk for TB?

Tuberculosis (TB) can affect anyone, but certain groups are more vulnerable to TB than others. People who are frequently in contact with active TB cases in their home or workplace are more likely to be infected with TB. Those who are immunosuppressed or immunocompromised are more likely to progress from TB infection to active TB disease.  

What groups are at higher risk for tuberculosis?

Groups at higher risk for tuberculosis infection (TBI) include close contacts of active TB cases, people from areas with a high incidence of TB, healthcare workers, children and residents or employees of congregate settings like long-term care and correctional facilities. 

People more likely to progress from TB infection to active TB disease include those who were recently infected, people living with HIV, those receiving immunosuppressive therapy (such as TNF-a inhibitors), and children aged <5 years.

What is a TB risk assessment?

A TB risk assessment helps to identify people at risk for tuberculosis who may require testing for TB infection or additional medical evaluation. Risk assessment is often part of a routine medical evaluation, especially for those entering a high-risk employment or living setting such as a healthcare facility, correctional facility, school or university. 

TB risk factors

Risk factors for tuberculosis include certain medical conditions, country of birth, recent close contact with TB and recent travel history. Risk factors identified by the WHO and the US CDC include (1,2): 

  • Conditions such as HIV/AIDS, cancer or organ transplant
  • Dialysis or Chronic Kidney Disease (CKD)
  • Immunosuppression, TNF inhibitors, corticosteroids
  • Substance use disorder (e.g. drugs or alcohol)
  • Travel or extended stay in a high-TB-incidence country
  • Exposure to a contact with active TB disease
  • Employment or residence in a congregate setting

Certain unexplained symptoms, such as a cough lasting more than 2–3 weeks, fever, night sweats, weight loss or hemoptysis (coughing up blood), also warrant evaluation for TB disease

Detect TB infection with QuantiFERON
Help protect at-risk patients with QuantiFERON-TB Gold Plus – one tube, one visit, one objective result.

How is TB spread? 

Tuberculosis spreads through the air when a person with active TB in their lungs coughs, speaks, sings or sneezes. People nearby can inhale the bacteria and become infected. TB is not spread by touching surfaces, sharing food, or casual contact.

Tuberculosis in the United States

Up to 13 million people in the US are believed to carry TB infection (3). US TB cases rose for the fourth straight year in 2024, reaching their highest since 2011 (4). 

The reservoir of resurgent TB is silent TB infection. An effective program to end TB requires accurate detection of TB infection and early preventive treatment. Treating TB infection protects against debilitating TB disease – and helps stop the spread of TB. 

Tuberculosis is a global concern

10.8 million people fell ill with TB globally in 2023, and TB claimed 1.3 million lives. Childhood tuberculosis has risen 10% across Europe, with 225,000 people falling ill with TB and an estimated 22,500 deaths (2, 3).

The reservoir of resurgent TB is silent TB infection. An effective program to end TB requires accurate detection of TB infection and early preventive treatment. Treating TB infection protects against debilitating TB disease – and helps stop the spread of TB. 

Offer single-visit TB testing for your community

Primary care providers, community health centers and urgent cares all provide front-line testing and employment screening for their communities. 

Offering single-visit TB blood testing in collaboration with your laboratory partners lets you streamline testing and helps protect your at-risk patients.

Adopt an accurate and convenient latent TB test
Get in touch with us to find out more about latent TB testing solutions.
QuantiFERON-TB Gold Plus tubes

QuantiFERON is the world’s leading TB blood test

QuantiFERON-TB Gold Plus is more accurate than the skin test, unaffected by prior BCG vaccination, and uses a controlled laboratory assay to provide clear and objective results. 

References:
  1. US CDC. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis Infection — United States, 2010. MMWR59 RR-5
  2. US CDC. Tuberculosis — United States, 2023. https://www.cdc.gov/mmwr/volumes/73/wr/mm7312a4.htm
  3. US CDC. Tuberculosis – data and statistics. https://www.cdc.gov/tb/statistics/default.htm
  4. US Preventive Services Task Force. Screening for latent tuberculosis infection in adults. JAMA. 2016;316:962–969
  5. Lewinsohn DM, et al. Official ATS/IDSA/CDC clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111–115.

QFT -Plus is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assaessment, radiography, and other medical and diagnostic evaluations.

X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm